Background: Leishmaniasis is a globally important yet neglected parasitic disease transmitted by phlebotomine sand flies. With new candidate vaccines in or near the clinic, a controlled human challenge model (CHIM) using natural sand fly challenge would provide a method for early evaluation of prophylactic efficacy. Methods : We evaluated the biting frequency and adverse effects resulting from exposure of human volunteers to bites of either Phlebotomus papatasi or P. duboscqi, two natural vectors of Leishmania major. 12 healthy participants were recruited (mean age 40.2 ± 11.8 years) with no history of significant travel to regions where L. major-transmitting sand flies are prevalent. Participants were assigned to either vector by 1:1 allocation and exposed to five female sand flies for 30 minutes in a custom biting chamber. Bite frequency was recorded to confirm a bloodmeal was taken. Participant responses and safety outcomes were monitored using a visual analogue scale (VAS), clinical examination, and blood biochemistry. Focus groups were subsequently conducted to explore participant acceptability. Results: All participants had at least one successful sand fly bite with none reporting any serious adverse events, with median VAS scores of 0-1/10 out to day 21 post-sand fly bite. Corresponding assessment of sand flies confirmed that for each participant at least 1/5 sand flies had successfully taken a bloodmeal (overall mean 3.67±1.03 bites per participant). There was no significant difference between P. papatasi and P. duboscqi in the number of bites resulting from 5 sand flies applied to human participants (3.3±0.81 vs 3.00±1.27 bites per participant; p=0.56) . In the two focus groups (n=5 per group), themes relating to positive participant-reported experiences of being bitten and the overall study, were identified. Conclusions: These results validate a protocol for achieving successful sand fly bites in humans that is safe, well-tolerated and acceptable for participants. Clinicaltrials.gov registration: NCT03999970 (27/06/2019).

Department of Infection and Tropical Medicine Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK

Department of Microbiology and Molecular Genetics The Hebrew University Hadassah Medical School Jerusalem Israel

Department of Parasitology Charles University Prague Czech Republic

Laboratory of Malaria and Vector Research National Institutes of Health Rockville MD USA

Peninsula Medical School University of Plymouth Plymouth UK

School of Social Sciences Leeds Beckett University Leeds UK

York Biomedical Research Institute Hull York Medical School University of York York N Yorks YO10 5DD UK

Zobrazit více v PubMed

Control of Neglected Tropical Diseases. Reference Source

GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. 10.1016/S0140-6736(18)32203-7 PubMed DOI PMC

WHO: Weekly Epidemiological Record, 19 June 2020.WHO,2020;95(25):265–280. Reference Source

Alvar J, Vélez ID, Bern C, et al. : Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS One. 2012;7(5):e35671. 10.1371/journal.pone.0035671 PubMed DOI PMC

Leishmaniasis. Reference Source

GBD 2019 Diseases and Injuries Collaborators: Global burden of 369 diseases and injuries in 204 countries and territories, 1990– 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. 10.1016/S0140-6736(20)30925-9 PubMed DOI PMC

Bennis I, De Brouwere V, Belrhiti Z, et al. : Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review. BMC Public Health. 2018;18(1):358. 10.1186/s12889-018-5260-9 PubMed DOI PMC

Kamhawi S: Phlebotomine sand flies and Leishmania parasites: friends or foes? Trends Parasitol. 2006;22(9):439–45. 10.1016/j.pt.2006.06.012 PubMed DOI

Dostálová A, Volf P: Leishmania development in sand flies: Parasite-vector interactions overview. Parasit Vectors. 2012;5:276. 10.1186/1756-3305-5-276 PubMed DOI PMC

Chakravarty J, Sundar S: Current and emerging medications for the treatment of leishmaniasis. Expert Opin Pharmacother. 2019;20(10):1251–1265. 10.1080/14656566.2019.1609940 PubMed DOI

Travi BL, Cordeiro-da-Silva A, Dantas-Torres F, et al. : Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us. PLoS Negl Trop Dis. 2018;12(1):e0006082. 10.1371/journal.pntd.0006082 PubMed DOI PMC

Mondal D, Bern C, Ghosh D, et al. : Quantifying the infectiousness of post-kala-azar dermal leishmaniasis toward sand flies. Clin Infect Dis. 2019;69(2):251–258. 10.1093/cid/ciy891 PubMed DOI PMC

Wilson AL, Courtenay O, Kelly-Hope LA, et al. : The importance of vector control for the control and elimination of vector-borne diseases. PLoS Negl Trop Dis. 2020;14(1):e0007831. 10.1371/journal.pntd.0007831 PubMed DOI PMC

Le Rutte EA, Coffeng LE, Malvolti S, et al. : The potential impact of human visceral leishmaniasis vaccines on population incidence. PLoS Negl Trop Dis. 2020;14(7):e0008468. 10.1371/journal.pntd.0008468 PubMed DOI PMC

Gillespie PM, Beaumier CM, Strych U, et al. : Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016;34(26):2992–2995. 10.1016/j.vaccine.2015.12.071 PubMed DOI

Alvar J, Croft SL, Kaye P, et al. : Case study for a vaccine against leishmaniasis. Vaccine. 2013;31 Suppl 2:B244–B249. 10.1016/j.vaccine.2012.11.080 PubMed DOI

Palatnik-de-Sousa CB, Nico D: The Delay in the Licensing of Protozoal Vaccines: A Comparative History. Front Immunol. 2020;11:204. 10.3389/fimmu.2020.00204 PubMed DOI PMC

Payne RO, Griffin PM, McCarthy JS, et al. : Plasmodium vivax Controlled Human Malaria Infection - Progress and Prospects. Trends Parasitol. 2017;33(2):141–150. 10.1016/j.pt.2016.11.001 PubMed DOI PMC

Darton TC, Blohmke CJ, Moorthy VS, et al. : Design, recruitment, and microbiological considerations in human challenge studies. Lancet Infect Dis. 2015;15(7):840–51. 10.1016/S1473-3099(15)00068-7 PubMed DOI

Roestenberg M, Hoogerwerf MA, Ferreira DM, et al. : Experimental infection of human volunteers. Lancet Infect Dis. 2018;18(10):e312–e322. 10.1016/S1473-3099(18)30177-4 PubMed DOI

Gould VMW, Francis JN, Anderson KJ, et al. : Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre. Front Microbiol. 2017;8:900. 10.3389/fmicb.2017.00900 PubMed DOI PMC

Newman KL, Marsh Z, Kirby AE, et al. : Immunocompetent adults from human norovirus challenge studies do not exhibit norovirus viremia. J Virol. 2015;89(13):6968–9. 10.1128/JVI.00392-15 PubMed DOI PMC

Kirkpatrick BD, Whitehead SS, Pierce KK, et al. : The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci Transl Med. 2016;8(330):330ra36. 10.1126/scitranslmed.aaf1517 PubMed DOI

Ferreira DM, Neill DR, Bangert M, et al. : Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med. 2013;187(8):855–64. 10.1164/rccm.201212-2277OC PubMed DOI PMC

Langenberg MCC, Hoogerwerf MA, Koopman JPR, et al. : A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics. Nat Med. 2020;26(3):326–332. 10.1038/s41591-020-0759-x PubMed DOI

Eyal N, Lipsitch M, Smith PG: Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure. J Infect Dis. 2020;221(11):1752–1756. 10.1093/infdis/jiaa152 PubMed DOI PMC

Shah SK, Miller FG, Darton TC, et al. : Ethics of controlled human infection to address COVID-19. Science. 2020;368(6493):832–834. 10.1126/science.abc1076 PubMed DOI

Peters NC, Bertholet S, Lawyer PG, et al. : Evaluation of Recombinant Leishmania Polyprotein Plus Glucopyranosyl Lipid A Stable Emulsion Vaccines against Sand Fly-Transmitted Leishmania major in C57BL/6 Mice. J Immunol. 2012;189(10):4832–41. 10.4049/jimmunol.1201676 PubMed DOI PMC

Dey R, Joshi AB, Oliveira F, et al. : Gut Microbes Egested during Bites of Infected Sand Flies Augment Severity of Leishmaniasis via Inflammasome-Derived IL-1β. Cell Host Microbe. 2018;23(1):134–143.e6. 10.1016/j.chom.2017.12.002 PubMed DOI PMC

DeSouza-Vieira T, Iniguez E, Serafim TD, et al. : Heme Oxygenase-1 Induction by Blood-Feeding Arthropods Controls Skin Inflammation and Promotes Disease Tolerance. Cell Rep. 2020;33(4):108317. 10.1016/j.celrep.2020.108317 PubMed DOI

Nagill R, Kaur S: Vaccine candidates for leishmaniasis: A review. Int Immunopharmacol. 2011;11(10):1464–88. 10.1016/j.intimp.2011.05.008 PubMed DOI

Khamesipour A, Dowlati Y, Asilian A, et al. : Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005;23(28):3642–3648. 10.1016/j.vaccine.2005.02.015 PubMed DOI

Mohebali M, Nadim A, Khamesipour A: An overview of leishmanization experience: A successful control measure and a tool to evaluate candidate vaccines. Acta Trop. 2019;200:105173. 10.1016/j.actatropica.2019.105173 PubMed DOI

Osman M, Mistry A, Keding A, et al. : A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl Trop Dis. 2017;11(5):e0005527. 10.1371/journal.pntd.0005527 PubMed DOI PMC

Duthie MS, Pereira L, Favila M, et al. : A defined subunit vaccine that protects against vector-borne visceral leishmaniasis. NPJ Vaccines. 2017;2:23. 10.1038/s41541-017-0025-5 PubMed DOI PMC

Laurent I, et al. : Leishmania vaccine using sand fly salivary immunogen.2013;2.

IRCT: Evaluations of double blind randomized controlled clinical trial, single dose of the gentamicin-attenuated line of Leishmania major H-line vaccine against cutaneous leishmaniasis in comparison with phosphate buffer solution control group in west of Iran. Reference Source

Zabala-Peñafiel A, Todd D, Daneshvar H, et al. : The potential of live attenuated vaccines against Cutaneous Leishmaniasis. Exp Parasitol. 2020;210:107849. 10.1016/j.exppara.2020.107849 PubMed DOI

Zhang WW, Karmakar S, Gannavaram S, et al. : A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat Commun. 2020;11(1):3461. 10.1038/s41467-020-17154-z PubMed DOI PMC

Cecílio P, Oristian J, Meneses C, et al. : Engineering a vector-based pan- Leishmania vaccine for humans: proof of principle. Sci Rep. 2020;10(1):18653. 10.1038/s41598-020-75410-0 PubMed DOI PMC

Lestinova T, Rohousova I, Sima M, et al. : Insights into the sand fly saliva: Blood-feeding and immune interactions between sand flies, hosts, and Leishmania. PLoS Negl Trop Dis. 2017;11(7):e0005600. 10.1371/journal.pntd.0005600 PubMed DOI PMC

Atayde VD, Aslan H, Townsend S, et al. : Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut. Cell Rep. 2015;13(5):957–67. 10.1016/j.celrep.2015.09.058 PubMed DOI PMC

Atayde VD, Hassani K, da Silva Lira Filho A, et al. : Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions. Cell Immunol. 2016;309:7–18. 10.1016/j.cellimm.2016.07.013 PubMed DOI

Kaye PM, Cruz I, Picado A, et al. : Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs. Semin Immunopathol. 2020;42(3):247–264. 10.1007/s00281-020-00788-y PubMed DOI

Vinhas V, Andrade BB, Paes F, et al. : Human anti-saliva immune response following experimental exposure to the visceral leishmaniasis vector, Lutzomyia longipalpis. Eur J Immunol. 2007;37(11):3111–21. 10.1002/eji.200737431 PubMed DOI

Luz NF, DeSouza-Vieira T, De Castro W, et al. : Lutzomyia longipalpissaliva induces heme oxygenase-1 expression at bite sites. Front Immunol. 2018;9:2779. 10.3389/fimmu.2018.02779 PubMed DOI PMC

Oliveira F, Traoré B, Gomes R, et al. : Delayed-type hypersensitivity to sand fly saliva in humans from a leishmaniasis-endemic area of mali is TH1-mediated and persists to midlife. J Invest Dermatol. 2013;133(2):452–9. 10.1038/jid.2012.315 PubMed DOI PMC

Immune Responses After Human Subject Challenge With Sand Fly Bites.Full Text View - ClinicalTrials.gov. Reference Source

Parkash V, Jones G, Martin N, et al. : Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis. Res Involv Engagem. 2021;7(1):33. 10.1186/s40900-021-00277-y PubMed DOI PMC

Kaye P: A controlled human infection model for sand fly-transmitted cutaneous leishmaniasis.2021. 10.17605/OSF.IO/H3UCA PubMed DOI

A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol.Full Text View - ClinicalTrials.gov. Reference Source

Herrington DA, Clyde DF, Murphy JR, et al. : A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines. Trop Geogr Med. 1988;40(2):124–127. PubMed

Cheng Q, Lawrence G, Reed C, et al. : Measurement of Plasmodium falciparum growth rates in vivo: A test of malaria vaccines. Am J Trop Med Hyg. 1997;57(4):495–500. 10.4269/ajtmh.1997.57.495 PubMed DOI

Home - Leish Challenge. Reference Source

Sherrill DL, Halonen M, Burrows B: Relationships between total serum IgE, atopy, and smoking: A twenty-year follow-up analysis. J Allergy Clin Immunol. 1994;94(6 Pt 1):954–62. 10.1016/0091-6749(94)90113-9 PubMed DOI

Ben-Shoshan M, Clarke AE: Anaphylaxis: Past, present and future. Allergy. 2011;66(1):1–14. 10.1111/j.1398-9995.2010.02422.x PubMed DOI

Volf P, Volfova V: Establishment and maintenance of sand fly colonies. J Vector Ecol. 2011;36 Suppl 1:S1–S9. 10.1111/j.1948-7134.2011.00106.x PubMed DOI

Lawyer P, Killick-Kendrick M, Rowland T, et al. : Laboratory colonization and mass rearing of phlebotomine sand flies (Diptera, Psychodidae). Parasite. 2017;24:42. 10.1051/parasite/2017041 PubMed DOI PMC

Killick-Kendrick R: The biology and control of Phlebotomine sand flies. Clin Dermatol. 1999;17(3):279–89. 10.1016/s0738-081x(99)00046-2 PubMed DOI

Benkova I, Volf P: Effect of temperature on metabolism of Phlebotomus papatasi (Diptera: Psychodidae). J Med Entomol. 2007;44(1):150–4. PubMed

Rohousova I, Ozensoy S, Ozbel Y, et al. : Detection of species-specific antibody response of humans and mice bitten by sand flies. Parasitology. 2005;130(Pt 5):493–9. 10.1017/s003118200400681x PubMed DOI

Clements MF, Gidwani K, Kumar R, et al. : Measurement of recent exposure to Phlebotomus argentipes, the vector of indian visceral leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg. 2010;82(5):801–7. 10.4269/ajtmh.2010.09-0336 PubMed DOI PMC

Hamilton JG, Ramsoondar TM: Attraction of Lutzomyia longipalpis to human skin odours. Med Vet Entomol. 1994;8(4):375–80. 10.1111/j.1365-2915.1994.tb00101.x PubMed DOI

Rebollar-Tellez EA, Hamilton JGC, Ward RD: Response of female Lutzomyia longipalpis to host odour kairomones from human skin. Physiol Entomol. 1999;24(3):220–226. 10.1046/j.1365-3032.1999.00133.x DOI

Nevatte TM, Ward RD, Sedda L, et al. : After infection with Leishmania infantum, Golden Hamsters ( Mesocricetus auratus) become more attractive to female sand flies ( Lutzomyia longipalpis). Sci Rep. 2017;7(1):6104. 10.1038/s41598-017-06313-w PubMed DOI PMC

Simpson CR, Sheikh A: Adrenaline is first line treatment for the emergency treatment of anaphylaxis. Resuscitation. 2010;81(6):641–2. 10.1016/j.resuscitation.2010.04.002 PubMed DOI

Caroline Tynan A, Drayton JL: CONDUCTING FOCUS GROUPS — A GUIDE FOR FIRST‐TIME USERS. Mark Intell Plan. 1988;6(1):5–9. 10.1108/eb045757 DOI

Noble H, Smith J: Issues of validity and reliability in qualitative research. Evid Based Nurs. 2015;18(2):34–35. 10.1136/eb-2015-102054 PubMed DOI

Braun V, Clarke V: Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. 10.1191/1478088706qp063oa DOI

Friese S: Qualitative Data Analysis with ATLAS.ti.SAGE Publications,2019. Reference Source

Elo S, Kääriäinen M, Kanste O, et al. : Qualitative Content Analysis: A Focus on Trustworthiness. SAGE Open. 2014;4:215824401452263. 10.1177/2158244014522633 DOI

U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS: Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events.Corrected. Reference Source

Reich A, Heisig M, Phan NQ, et al. : Visual analogue scale: Evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol. 2012;92(5):497–501. 10.2340/00015555-1265 PubMed DOI

Senekji HA, Beattie CP: Artificial infection and immunization of man with cultures of leishmania tropica. Trans R Soc Trop Med Hyg. 1941;34(6):415–419. 10.1016/S0035-9203(41)90027-5 DOI

Melby PC: Experimental leishmaniasis in humans: review. Rev Infect Dis. 1991;13(5):1009–17. 10.1093/clinids/13.5.1009 PubMed DOI

Adler S: Attempts to transmit visceral leishmaniasis to man: Remarks on the histopathology of leishmaniasis. Trans R Soc Trop Med Hyg. 1940;33(4):419–426. 10.1016/S0035-9203(40)90043-8 DOI

de la Tribonnière X: [b1 b2] (analytic). Edmond SERGENT (1876-1969) et l’Institut Pasteur d’Algérie (French). Edmond SERGENT Pasteur Inst Alger. (1AD).

Adler S, Theodor O: The transmission of leishmania tropica from artificially infected sandflies to man. Ann Trop Med Parasitol. 1927;21(2):89–110. 10.1080/00034983.1927.11684523 DOI

Theodor O: A study of the reaction to phlebotomus bites with some remarks on “Harara”. Trans R Soc Trop Med Hyg. 1935;29(3):273–284. 10.1016/S0035-9203(35)90090-6 DOI

Adler S, Ber M: Transmission of Leishmania tropica by the Bite of Phlebotomus papatasii. Nature. 1941;148:227. 10.1038/148227a0 DOI

Swaminath CS, Shortt HE, Anderson LA: Transmission of Indian kala-azar to man by the bites of Phlebotomus argentipes, ann and brun. 1942. Indian J Med Res. 2006;123(3):473–7. PubMed

Lainson R, Strangways-Dixon J: Leishmania mexicana: The epidemiology of dermal leishmaniasis in British Honduras. Trans R Soc Trop Med Hyg. 1963;242–65. 10.1016/0035-9203(63)90182-2 PubMed DOI

Peters W, Bryceson A, Evans DA, et al. : Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man. Trans R Soc Trop Med Hyg. 1990;84(5):681–9. 10.1016/0035-9203(90)90145-5 PubMed DOI

Ashwin H, Sadlova J, Vojtkova B, et al. : Characterization of a new Leishmania major strain for use in a controlled human infection model. Nat Commun. 2021;12(1):215. 10.1038/s41467-020-20569-3 PubMed DOI PMC

Belkaid Y, Valenzuela JG, Kamhawi S, et al. : Delayed-type hypersensitivity to Phlebotomus papatasi sand fly bite: An adaptive response induced by the fly? Proc Natl Acad Sci U S A. 2000;97(12):6704–9. 10.1073/pnas.97.12.6704 PubMed DOI PMC

Klotz JH, Klotz SA, Pinnas JL: Animal Bites and Stings with Anaphylactic Potential. J Emerg Med. 2009;36(2):148–56. 10.1016/j.jemermed.2007.06.018 PubMed DOI

Crocker JC, Ricci-Cabello I, Parker A, et al. : Impact of patient and public involvement on enrolment and retention in clinical trials: Systematic review and meta-analysis. BMJ. 2018;363:k4738. 10.1136/bmj.k4738 PubMed DOI PMC

Bagley HJ, Short H, Harman NL, et al. : A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress. Res Involv Engagem. 2016;2:15. 10.1186/s40900-016-0029-8 PubMed DOI PMC

Li L, Liu X, Herr K: Postoperative pain intensity assessment: A comparison of four scales in Chinese adults. Pain Med. 2007;8(3):223–34. 10.1111/j.1526-4637.2007.00296.x PubMed DOI

Flytström I, Stenberg B, Svensson Å, et al. : Patients’ visual analogue scale: A useful method for assessing psoriasis severity. Acta Derm Venereol. 2012;92(4):347–9. 10.2340/00015555-1237 PubMed DOI

Reunala T, Brummer-Korvenkontio H, Petman L, et al. : Effect of ebastine on mosquito bites. Acta Derm Venereol. 1997;77(4):315–6. PubMed

Jao I, Marsh V, Chi PC, et al. : Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan-based malaria infection study. Bioethics. 2020;34(8):819–832. 10.1111/bioe.12781 PubMed DOI PMC

Njue M, Njuguna P, Kapulu MC, et al. : Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya [version 1; referees: 2 approved]. Wellcome Open Res. 2018;3:39. 10.12688/wellcomeopenres.14439.1 PubMed DOI PMC

Kapumba BM, Jambo K, Rylance J, et al. : Stakeholder views on the acceptability of human infection studies in Malawi. BMC Med Ethics. 2020;21(1):14. 10.1186/s12910-020-0454-y PubMed DOI PMC

Gbesemete D, Barker M, Lawrence WT, et al. : Exploring the acceptability of controlled human infection with SARSCoV2 - A public consultation. BMC Med. 2020;18(1):209. 10.1186/s12916-020-01670-2 PubMed DOI PMC

Rogers ME, Bates PA: Leishmania manipulation of sand fly feeding behavior results in enhanced transmission. PLoS Pathog. 2007;3(6):e91. 10.1371/journal.ppat.0030091 PubMed DOI PMC

Teixeira C, Gomes R, Oliveira F, et al. : Characterization of the Early Inflammatory Infiltrate at the Feeding Site of Infected Sand Flies in Mice Protected from Vector-Transmitted Leishmania major by Exposure to Uninfected Bites. PLoS Negl Trop Dis. 2014;8(4):e2781. 10.1371/journal.pntd.0002781 PubMed DOI PMC

Oliveira F, Rowton E, Aslan H, et al. : A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates. Sci Transl Med. 2015;7(290):290ra90. 10.1126/scitranslmed.aaa3043 PubMed DOI

El Hajj L, Thellier M, Carrière J, et al. : Localized cutaneous leishmaniasis imported into Paris: A review of 39 cases. Int J Dermatol. 2004;43(2):120–5. 10.1111/j.1365-4632.2004.01991.x PubMed DOI

McLafferty I: Focus group interviews as a data collecting strategy. J Adv Nurs. 2004;48(2):187–94. 10.1111/j.1365-2648.2004.03186.x PubMed DOI

Morgan D: Focus groups. Annu Rev Sociol. 1996;22:129–152. 10.1146/annurev.soc.22.1.129 DOI

Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis

Zobrazit více v PubMed

ClinicalTrials.gov
NCT03999970